Unusual skin reactions after mosquito bites and Epstein-Barr virus reactivation in a patient with matle cell lymphoma

Internal Medicine

Volumn 43, Issue 10, 2004, Pages 986-989

  Shigekiyo, Toshio ^a   Ohmori, Hiroko ^a   Chohraru, Masahito ^a   Ohtsuka, Shinsaku ^a   Yamabe, Kazue ^a   Takishita, Yashihiro ^a   Takai, Shigeharu ^a   Takahashi, Masanori ^a   Wakatsuki, Shingo ^b  

^a TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

Author keywords

Chronic active Epstein Barr virus infection; Chronic Epstein Barr virus infection; Epstein Barr virus; Epstein Barr virus reactivation; Hypersensitivity to mosquito bites; Mantle cell lymphoma

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; CISPLATIN; CLADRIBINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISOLONE; VINCRISTINE; VIRUS CAPSID ANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; CELL NUCLEUS; CYTOPLASM; EPSTEIN BARR VIRUS; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; INSECT BITE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTE; LYMPHOCYTOSIS; LYMPHOMA CELL; MALE; MANTLE CELL LYMPHOMA; MOSQUITO; PATIENT REFERRAL; PNEUMONIA; SKIN MANIFESTATION; VIRUS DETECTION; VIRUS REACTIVATION;

ANIMALS; CULICIDAE; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INSECT BITES AND STINGS; LYMPH NODES; LYMPHATIC DISEASES; LYMPHOCYTOSIS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; SKIN;

EID: 8844226677     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.986     Document Type: Article

References (13)

1. Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol 45: 569-578, 2001.
2. Ishihara S, Okada S, Wakiguchi H, Kurashige T, Hirai K, Kawa-Ha K. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol 54: 276-281, 1997.
3. Mori T, Okamoto S, Kuramochi S, Ikeda Y. An adult patient with hypersensitivity to mosquito bites developing mantle cell lymphoma. Int J Hematol 71: 259-262, 2000.
4. Kawa K. Epstein-Barr virus-associated diseases in humans. Int J Hematol 71: 108-117, 2000.
5. Zucca E, Stein H, Coiffier B. European lymphoma task force (ELTF): report of the workshop on mantle cell lymphoma (MCL). Ann Oncol 5: 507-511, 1994.
6. Rummel MJ, Chow KU, Karakas T, et al. Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma. Eur J Cancer 38: 1739-1746, 2002.
7. Ogura M, Kagami Y, Taji H, et al. Pilot phase I/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma. Int J Hematol 77: 503-511, 2003.
8. Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J Exp Med 169: 2191-2198, 1989.
9. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47: 883-889, 1986.
10. Straus SE. The chronic mononucleosis syndrome. J Infect Dis 157: 405-412, 1988.
11. Hummel M, Anagnostopoulos I, Korbjuhn P, Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: Unexpected infection patterns and different infection incidence in low-and high-grade types. J Pathol 175: 263-271, 1995.
12. Daibata M, Kubonishi I, Eguchi T, Yano S, Ohtsuki Y, Miyoshi I. The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma. Cancer 64: 1248-1253, 1989.
13. Daibata M, Kubonishi I, Miyoshi I. Differential tumorigenicity between Epstein-Barr virus genome-positive and genome-negative cell lines with t(11;14(q13;q32) derived from mantle cell lymphoma. J Virol 70: 9003-9007, 1996.